Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Liabilities from Discontinued Operations (2024 - 2025)

Standard Biotools (LAB) has disclosed Liabilities from Discontinued Operations for 2 consecutive years, with 25633000.0 as the latest value for Q4 2025.

  • Quarterly Liabilities from Discontinued Operations rose 23.21% to 25633000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 25633000.0 through Dec 2025, up 23.21% year-over-year, with the annual reading at 25633000.0 for FY2025, 23.21% up from the prior year.
  • Liabilities from Discontinued Operations for Q4 2025 was 25633000.0 at Standard Biotools, up from 17984000.0 in the prior quarter.
  • The five-year high for Liabilities from Discontinued Operations was 25633000.0 in Q4 2025, with the low at 17984000.0 in Q2 2025.